clinical evidence for the impact of the intestinal microflora is based on the beneficial effect of antimicrobial agents , especially metronidazole , and on the demonstration of immunologic phenomena involving antigens of bacterial origin .
C1136254
antimicrobial agents
C0025872
metronidazole